Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
In this month’s roundup of key lab-related cases, a bizarre twist in the Theranos saga leads to a slim chance of a mistrial.
Most of the recent settlements and enforcement actions involving labs related to medically unnecessary UDTs and genetic tests.
An overview and general briefing on some of the most common ICD codes concerns for labs.
How to create a written policy banning retaliation for whistleblowing and for investigating retaliation complaints.
What happens when a compliance officer is the whistleblower in a qui tam retaliation lawsuit?
This useful template can be used to develop a clear written policy on time theft for your lab in order to help prevent it.
Six common forms of time theft to be on the lookout for, and how lab leaders can stop each one.
Due to the common misuse of this modifier, the Centers for Medicare & Medicaid Services recently issued important new guidance on its proper use.
This month’s key lab cases involve false billing of urine drug and PGx tests and two lawsuits that were tossed.
A recent $3.5 million settlement illustrates the kinds of pitfalls that can result in liability for hospital and freestanding sleep labs.